Loading
A phase 1/2 trial of ipilimumab, pembrolizumab and durvalumab in pancreatic cancer, run by Second Affiliated Hospital of Guangzhou Medical University, now recruiting.
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors is a phase 1/2, interventional study registered as NCT05187338 by Second Affiliated Hospital of Guangzhou Medical University, with a registry enrolment figure of 100 participants, started 2021-11-01 and due to reach its primary completion in 2029-10-30. Interventions recorded: ipilimumab +pembrolizumab +durvalumab. Conditions listed: Lung Cancer; Liver Cancer; Colorectal Cancer; Pancreas Cancer; Ovary Cancer; Head and Neck Cancer; Breast Cancer; Gastric Cancer; Cervical Cancer; Esophageal Cancer; Sarcoma. Primary outcome: Safety of 3 drugs combination treatment; Progression-free survival; Disease control rate. Sites: China. No results are recorded here; the registry entry is the source.
Shares Durvalumab, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Pembrolizumab, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Pembrolizumab, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Ipilimumab, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.